Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Viyaasan Mahalingasivam

BMedSci MBBS MRCP MSc

Research Fellow

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Jump to: Affiliations Research Publications

I graduated from Barts and The London School of Medicine & Dentistry in 2010 and subsequently completed training in Nephrology and General Internal Medicine on the North Thames rotation in London. I undertook a Masters degree in Epidemiology at the London School of Hygiene & Tropical Medicine in 2017-19, and returned to commence an NIHR Doctoral Research Fellowship in 2021. I continue to do clinical work as an honorary consultant nephrologist at Barts Health NHS Trust.

Affiliations
Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Research

I work with routinely-collected electronic health records and am investigating the impact of COVID-19 on kidney disease.

Research Area
Clinical databases
Electronic health records
Discipline
Epidemiology
Medicine
Disease and Health Conditions
Cardiovascular disease
Diabetes
Kidney disease
Non-communicable diseases
Coronavirus

Selected Publications
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.
Costello RE; Tazare J; Piehlmaier D; Herrett E; Parker EPK; Zheng B; Mansfield KE; Henderson AD; Carreira H; Bidulka P
2023
EClinicalMedicine
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.
Green ACA; Curtis HJ; Higgins R; Nab L; Mahalingasivam V; Smith RM; Mehrkar A; Inglesby P; Drysdale H; DeVito NJ
2023
BMJ Medicine
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT).
Herrett E; Tomlin K; Lin L-Y; Tomlinson LA; Jit M; Briggs A; Marks M; Sandmann F; Parry J; Bates C
2023
BMJ Open
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.
Hopcroft LE; Curtis HJ; Brown AD; Hulme WJ; Andrews CD; Morton CE; Inglesby P; Morley J; Mehrkar A; Bacon SC
2023
Wellcome open research
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
OpenSAFELY Collaborative; Parker EP; Tazare J; Hulme WJ; Bates C; Carr EJ; Cockburn J; Curtis HJ; Fisher L; Green AC
2023
BMJ Open
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
OpenSAFELY Collaborative; Parker EPK; Horne EMF; Hulme WJ; Tazare J; Zheng B; Carr EJ; Loud F; Lyon S; Mahalingasivam V
2023
The Lancet regional health. Europe
Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform
The OpenSAFELY collaborative; Tazare J; Nab L; Zheng B; Hulme W; Green A; Curtis H; Mahalingasivam V; Higgins R; Schultze A
2023
medRxiv
Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: An analysis of monthly changes in Quality and Outcomes Framework indicators in OpenSAFELY
Wiedemann M; Speed V; Cunningham C; Higgins R; Curtis HJ; Andrews C; Fisher L; Hopcroft LEM; Rentsch CT; Mahalingasivam V
2023
Cold Spring Harbor Laboratory
See more Publications
Viyaasan Mahalingasivam

Contact

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom